AI
Arteris, Inc. (AIP)·Q4 2024 Earnings Summary
Executive Summary
- Q4 revenue was $15.5M, up 24% YoY, with GAAP gross margin at 90% and non-GAAP gross margin at 91%; record ACV + royalties reached $65.1M and record RPO hit $88.4M .
- Non-GAAP operating loss improved to $2.8M, a clear beat versus prior Q4 guidance of $4.0–$5.0M; GAAP net loss was $8.2M ($0.20 per share) and non-GAAP net loss was $3.9M ($0.10 per share) .
- Free cash flow was -$2.7M, missing Q4 guidance (-$0.9M to +$1.1M) due to working capital timing; the company ended Q4 with ~$52.3M cash, cash equivalents, and investments, and no financial debt .
- Q1 2025 guidance: revenue $15.7–$16.1M; FY 2025 revenue: $66.0–$70.0M; both accompanied by improving non-GAAP operating loss ranges and a target to turn positive FY free cash flow ($1.0–$7.0M) .
- Product and commercial catalysts: FlexGen Smart NoC (up to 10x engineering productivity, ~30% wire-length improvement in complex SoCs), expanding MCU wins (Infineon, GigaDevice), and rising chiplet projects that increase ASPs and license counts per design .
What Went Well and What Went Wrong
What Went Well
- Record commercial metrics: ACV + royalties reached $65.1M and RPO rose to $88.4M, both record highs, reflecting strong deal flow and customer expansion, including top-tier tech and automotive wins .
- Operating efficiency and margin stability: non-GAAP operating loss improved to $2.8M; GAAP/non-GAAP gross margin held at ~90%/91%; management emphasized prudent OpEx control and expects further improvement in 2025 .
- Strategic product momentum: FlexGen Smart NoC announced (AI-driven automation, up to 10x engineering productivity, and power/latency gains); >75% of FlexNoC customers chose physically aware FlexNoC 5; management: “FlexGen…providing expert-level NoC topologies in hours or days instead of weeks” .
What Went Wrong
- Free cash flow miss: Q4 FCF came in at -$2.7M, below guidance, driven by receivables timing (customer payments slipped post-quarter close), despite full-year FCF of -$1.0M .
- Royalties composition: the “royalties and other” line was slightly lower YoY due to fewer one-time audit benefits vs. 2023; variable royalties grew 20% YoY, and >30% ex-Mobileye, but Mobileye’s inventory correction weighed on automotive royalty mix .
- Balance sheet equity: stockholders’ equity turned negative (-$1.2M) at year-end despite ~$52.3M liquidity and no financial debt, highlighting cumulative losses and deferred revenue liabilities .
Financial Results
Core Financials (GAAP)
Non-GAAP Metrics
Revenue Breakdown
KPIs
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- CEO: “In the fourth quarter of 2024, we achieved a record annual contract value, plus royalties, of $65.1 million…fueled by increased adoption of AI-driven enterprise computing and automotive SoCs” .
- CEO on FlexGen: “FlexGen…delivering up to 10x engineering productivity…reduces manual iteration by over 90%…expert-level NoC topologies in hours or days” .
- CFO: “Non-GAAP operating loss in the quarter was $2.8 million, which came in above the top end of our guidance range…We ended the quarter with [$52.3 million] in cash, cash equivalents and investments, and we have no financial debt” .
- Strategy: mix-and-match interconnect approach with ARM CMN + FlexNoC; involvement in PC chipsets (x86) broadens architecture-neutral footprint .
Q&A Highlights
- Bookings strength: Q4 characterized as strong deal flow; typical seasonal peak in bookings in Q4 .
- Pricing/ASP: Complex SoC ASPs tracking toward ~$1M per project; FlexGen uplift ~30%; MCUs carry lower ASPs but higher volumes; buying “everything” could be ~$1.5M per project .
- Royalties dynamics: “Royalties and other” slightly lower YoY due to fewer audit benefits; variable royalties +20% YoY, and >30% YoY ex-Mobileye; auto still ~half of variable royalties .
- Free cash flow seasonality: cash inflows weighted to 2H; Q4 FCF miss due to receivables timing; targeting positive FY 2025 FCF .
- Chiplets: more complexity, multiple dies and companies → higher ASPs and more licenses per program .
Estimates Context
- S&P Global consensus EPS and revenue estimates were unavailable due to API limit constraints; as a result, we cannot provide Wall Street consensus comparisons for Q4 2024, Q3 2024, Q2 2024, or FY 2025. Values would normally be retrieved from S&P Global, but were not accessible at this time.
Key Takeaways for Investors
- Commercial momentum is strong: record ACV + royalties ($65.1M) and record RPO ($88.4M) point to durable demand and multi-quarter visibility .
- Profitability trajectory improving: non-GAAP operating loss improved to $2.8M, beating guidance; OpEx discipline continues; FY 2025 guide implies further losses narrowing .
- Free cash flow miss appears timing-related: Q4 FCF - $2.7M due to receivables timing; management targets positive FY 2025 FCF .
- Product catalysts: FlexGen Smart NoC (10x productivity) and FlexNoC 5 (>75% adoption) should support pricing power and customer penetration, especially in complex AI SoCs .
- Mix evolution: chiplets likely lift ASPs and license counts per program; MCU expansion (Infineon, GigaDevice) lowers ASPs but increases royalty scale and design counts .
- Royalties resilience: variable royalties +20% YoY and >30% ex-Mobileye suggest underlying strength despite auto-specific headwinds .
- Liquidity sound: ~$52.3M cash/investments and no financial debt provide runway, though negative equity (-$1.2M) is a watch item for capital structure improvements .
Financial Appendix: Additional Business Highlights (Q4 timeframe)
- Selected by TIER IV for intelligent vehicles (Oct 29, 2024); Tenstorrent expanded deployment of Arteris NoCs (Nov 5, 2024); GigaDevice licensed FlexNoC 5 for automotive MCUs (Nov 19, 2024) .
- Partnership with SiFive delivering pre-verified RISC-V datacenter solutions (Oct 21, 2024); NoC tiling innovation announced to accelerate semiconductor design (Oct 15, 2024) .